ArticleBritish journal of cancer2023

Combination of pembrolizumab and pelareorep promotes anti-tumour immunity in advanced pancreatic adenocarcinoma (PDAC).

Devalingam Mahalingam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.